drugset

drugset / Trial / NCT06338241

Osteogenic Action of a Biphasic Bioceramic With Statin in a Third Molar Extraction Model

NCT06338241 ↗

Phase 4 Unknown 30 enrolled Mario Pérez Sayáns Universidad de Murcia · collab

RandomizedParallel-groupDouble-blindTreatment

Summary

The clinical study aims to assess the osteogenic effects of Galibone+ in bone regeneration post-extraction of impacted mandibular third molars.

Timeline

Start: 2024-03-02
Primary completion: 2025-06-02
Completion: 2025-09-02

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Galibone+	Unknown	—	Other

Indications